Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)

Updated

Vertex Pharmaceuticals (VRTX) recorded Convertible Debt of $400 million in Q1 2013, unchanged from $400 million a year earlier and unchanged from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013) Analysis & Trends

Starting with Q1 2010, Vertex Pharmaceuticals' Convertible Debt history includes 11 quarters.

  • Across earlier years, Convertible Debt came in at $400 million in FY2011 (unchanged) and $400 million in FY2010.
  • Per Business Quant, the preceding three quarters came in at $400 million (Q4 2012), $400 million (Q3 2012) and $400 million (Q2 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 400.00 Mn
Dec 31, 2012 400.00 Mn
Sep 30, 2012 400.00 Mn
Jun 30, 2012 400.00 Mn
Mar 31, 2012 400.00 Mn
Dec 31, 2011 400.00 Mn
Sep 30, 2011 400.00 Mn
Jun 30, 2011 400.00 Mn
Mar 31, 2011 400.00 Mn
Dec 31, 2010 400.00 Mn
Sep 30, 2010 400.00 Mn
Mar 31, 2010 32.10 Mn
API Access

Vertex Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY